APP Pharma nabs FDA nod for Zosyn copy; Ipsen in the market for new CFO;

@FiercePharma: France to stop paying for Pfizer's Champix. News | Follow @FiercePharma

> APP Pharmaceuticals won FDA approval to market a generic version Zosyn, Pfizer's injectable broad-spectrum antibiotic combining piperacillin and tazobactam. Report

> Ipsen's Claire Giraut, executive vice president and CFO, will leave her post as of September 1; the company will name a successor soon. Story

> Enzon Pharmaceuticals said it has named industry veteran Ana Stancic as senior vice president and chief financial officer. Article

> Bilfinger Berger has won a €30 million ($43 million) contract to help Genzyme add 8,000 liters of production capacity at its site in Geel, Belgium. Report

> Goldman Sachs analyst Mark Beards downgraded GlaxoSmithKline (GSK) today to "sell" from "neutral" on concerns that its above-average valuation doesn't jibe with its mediocre growth prospects and possible headwinds. Report

> SAC Capital Advisors is a focus of a Securities and Exchange Commission investigation into whether traders used inside information to profit from the $15 billion takeover of biotechnology firm MedImmune, people familiar with the matter say. Item

> Shares of AMAG Pharmaceuticals rose after an analyst upgraded the stock, saying he expects the stock price and sales of AMAG's drug Feraheme to recover. Article

> Bausch & Lomb intends to introduce a range of ophthalmic products in Indian market, as part of its plans to strengthen its presence globally. News

Biotech News

@FierceBiotech: Special Report: 5 emerging eClinical firms to watch. Article | Follow @FierceBiotech

@JohnCFierce: WSJ reports insider trading probe on SAC Capital and the MedImmune acquisition. Article | Follow @JohnCFierce

> Sanofi spurs layoff fears with Genzyme restructuring plans. News

> Novartis to showcase blockbuster cancer drug strategy at ASCO. Report

Drug Delivery News

> MAP Pharma files NDA for orally inhaled migraine treatment. Item

> Fluorescent carbon nanotubes light the way for drug-delivery researchers. Story

> Generex licenses buccal delivery to Amarantus for $10M. Report

> Why we love and hate the blood-brain barrier. Piece

> 'Theragnostic' nanoparticle detects and treats tumors. Article

> Packaging RNA for long-lasting, nontoxic delivery. Item

Medical Device News

> Boston Sci recalls imaging catheters. News

> Shuren to appear before House panel this week. Story

> Neoprobe sells gamma detection biz to Devicor. Item

> Advance Medical raises $6M in Series A. Article

And Finally... President Barack Obama's health care law, including its mandate that most Americans obtain insurance, goes before a U.S. appeals court, the second of at least three panels that will consider the act's constitutionality. Story